IVVD · Invivyd, Inc.
$0.62
-0.06 (-9.09%)
At close · Jul 22
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on current operating plans and excluding future external financing, the Company will not have sufficient cash and cash equivalents to fund its operating expenses and capital requirements beyond one year from the issuance of these condensed consolidated financial statements, and therefore, the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$182.69M
Shares
294.61M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.62
Open$0.68
Day$0.60–0.69
52W$0.48–3.07
Avg vol 30d5.7M
Short int27.4M · 9.3% float · 3.6d
Short vol30%
Last earningsMay 14, 2026
DataAug 2021–Jul 2026
Filing10-Q · May 14
Up next
Next earnings call
Sep 1, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−63%
below
Price vs 50-day avg
−37%
below
RSI (14)
29
oversold
MACD trend
Negative
52-week position
5%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−34%
trailing
6-month return
−68%
trailing
YTD return
−75%
this year
Relative strength
−75%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
8 of 140 funds reported for Jun 30 · net +45.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.31% of float · ▼ -20.3% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
140 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Revenue growth
+110%
Y/Y
EPS growth
+79%
Y/Y
Free cash flow
$-58.3M
Balance sheet
$226.7M
net cash
Quant / Vol
risk profile
Volatility
142%
annualized · 1-yr
Max drawdown
−78%
past year
ATR
12.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−63%
Bearish
Price vs 50-day avg
−37%
Bearish
RSI (14)
29
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
8 of 140 funds reported for Jun 30 · net +45.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.31% of float · ▼ -20.3% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
140 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $1 · 5%
52-wk high $3
vs 200-day avg -63%
vs 50-day avg -37%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IVVD
this stock
Invivyd, Inc.
|
$182.69M | -74.9% | +110.5% | — | 9.3% |
|
ONC
BeOne Medicines Ltd.
|
$462.38B | +5.3% | +22179.2% | 941.0 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$119.94B | +4.2% | +46.2% | 28.1 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.27B | -15.5% | +20.8% | 15.9 | 3.3% |
|
ARGX
Argenx SE
|
$57.84B | +9.9% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IVVD | -24.1% | -33.7% | -67.7% | -28.9% | -74.9% |
| SPY | -1.0% | +1.9% | +7.5% | +0.1% | +9.6% |
| vs SPY | -23.1% | -35.6% | -75.2% | -29.0% | -84.5% |